Invention Grant
US08110354B2 Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
有权
使用志贺氏菌invaplex在体外和体内在哺乳动物细胞膜中转运功能性蛋白质和转录活性核酸
- Patent Title: Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
- Patent Title (中): 使用志贺氏菌invaplex在体外和体内在哺乳动物细胞膜中转运功能性蛋白质和转录活性核酸
-
Application No.: US12563794Application Date: 2009-09-21
-
Publication No.: US08110354B2Publication Date: 2012-02-07
- Inventor: Edwin V. Oaks , Robert W. Kaminski
- Applicant: Edwin V. Oaks , Robert W. Kaminski
- Applicant Address: US DC Washington
- Assignee: The United States of America as represented by the Secretary of the Army
- Current Assignee: The United States of America as represented by the Secretary of the Army
- Current Assignee Address: US DC Washington
- Agent Elizabeth Arwine
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12N5/00

Abstract:
The in vivo and in vitro use of Invaplex to transport materials, including functional proteins and biologically active nucleic acids, across eukaryotic cell membranes. The eukaryotic cells include a variety of cell types, e.g. insect, reptile, fish, mammal and tumor cells. The suitable materials for transport include biochemicals such as reporter molecules, antibiotics, biopharmaceuticals and carbohydrates including polysaccharides, lipopolysaccharides, polynucleotides, such as DNA and RNA, and glycoproteins and proteins including antigens, enzymes, antibodies, receptors and hormones. In addition, Invaplex enhances the immune response to DNA vaccines and also can function by itself as a vaccine against shigellosis.
Public/Granted literature
Information query